Skip to main content

Advertisement

Log in

Methylphenidate: Use in Daily Practice

  • Published:
Pharmacy World and Science Aims and scope Submit manuscript

Abstract

Objective: With the aim of getting more insight into compliance of children using methylphenidate, we studied the day-to-day use of the drug. In addition, the efficacy and side effects of treatment, stopping, switching to other drugs and the use of additional psychoactive drugs in daily practice were studied.

Method: On the basis of pharmacy records, the use of methylphenidate by 52 children was studied. Two parameters for compliance were calculated. By means of a questionnaire, parents were asked about their children’s compliance with the use of methylphenidate as well as about their experience with treatment.

Main outcome measure: Compliance, use of methylphenidate in weekends and holidays, self-reported efficacy, side effects, stopping and switching to other drugs.

Results: Depending on the parameter calculated, the percentage of children with a good compliance varied from 25 to 47%. About 65% of the children used less or no methylphenidate in the weekends and holidays. Sixty-five percent of the parents reported to pass over a dose once in a while. According to 61% of the parents (n = 28) the efficacy of methylphenidate was good or very good. Nine (33%) of 28 children stopped using methylphenidate. Seven children stopped using the drug because of side-effects or lack of efficacy. Seven children switched to other psychoactive drugs. Fifty-seven percent of all children used additional psychoactive drugs.

Conclusion: The percentage of children having a good compliance calculated on the basis of pharmacy records is rather low. This is partly the result of the decreased use of methylphenidate in the weekends and holidays.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • DJ Safer JM. Krager (1994) ArticleTitleThe increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools Pediatrics 94 462–4 Occurrence Handle7936853

    PubMed  Google Scholar 

  • M Zwi P Ramchandani C. Joughin (2000) ArticleTitleEvidence and belief in ADHD BMJ 321 975–6 Occurrence Handle10.1136/bmj.321.7267.975 Occurrence Handle11039942

    Article  PubMed  Google Scholar 

  • E Schirm H Tobi JM. Zito (2001) ArticleTitlePsychotropic medication in children: a study from the Netherlands Pediatrics 108 IssueID2 e25 Occurrence Handle10.1542/peds.108.2.e25 Occurrence Handle11483835

    Article  PubMed  Google Scholar 

  • CG Berbatis VB Sunderland M. Bulsara (2002) ArticleTitleLicit psychostimulant consumption in Australia, 1984–2000: international and jurisdictional comparison Med J Aust 177 539–43 Occurrence Handle12429001

    PubMed  Google Scholar 

  • Gezondheidsraad: Diagnostiek en behandeling van ADHD. The Hague: Gezondheidsraad, 2000; publication no. 2000/24

  • JA Cramer RH Mattson ML Prevey RD Sceyer VL. Ouellette (1989) ArticleTitleHow often is medication taken as prescribed?. A novel assessment technique JAMA 261 3273–7 Occurrence Handle10.1001/jama.261.22.3273 Occurrence Handle2716163

    Article  PubMed  Google Scholar 

  • LH. Epstein (1984) ArticleTitleThe direct effects of compliance on health outcome Health Psychol 3 385–93 Occurrence Handle10.1037//0278-6133.3.4.385 Occurrence Handle6399250

    Article  PubMed  Google Scholar 

  • M Weintraub W Au L. Lasagna (1973) ArticleTitleCompliance as a determinant of serum digoxin concentration JAMA 224 481–5 Occurrence Handle10.1001/jama.224.4.481 Occurrence Handle4739606

    Article  PubMed  Google Scholar 

  • AHP Paes A Bakker CJ. Soe-Agnie (1997) ArticleTitleImpact of dosage frequency on patient’s compliance Diabetes Care 20 1512–6 Occurrence Handle9314626

    PubMed  Google Scholar 

  • T Pullar AD Birtwell PG Wiles A Hay MP. Freely (1988) ArticleTitleUse of a pharmacological indicator to investigate compliance with tablets to be taken once, twice or three times daily Clin Pharmacol Ther 44 540–5 Occurrence Handle3180635

    PubMed  Google Scholar 

  • J. Swanson (2003) ArticleTitleCompliance with stimulants for attention-deficit/hyperactivity disorder CNS Drugs 17 117–31 Occurrence Handle12521359

    PubMed  Google Scholar 

  • P. Firestone (1982) ArticleTitleFactors associated with children’s adherence to stimulant medication Am J Orthopsychiatr 21 474–9

    Google Scholar 

  • RT Brown KA Borden ME Wynne AL Spunt SR. Clingerman (1987) ArticleTitleCompliance with pharmacological and cognitive treatments for attention deficit disorder J Am Acad Child Adolesc Psychiatr 26 521–6

    Google Scholar 

  • R Bussing FA. Gary (2001) ArticleTitlePractical guidelines and parental ADHD treatment evaluations: friends or foes? Harvard Rev Psychiatr 9 223–33 Occurrence Handle10.1080/10673220127905

    Article  Google Scholar 

  • JF. Steiner (1997) ArticleTitleThe assessment of refill compliance using pharmacy records: methods, validity and applications J Clin Epidemiol 50 105–6 Occurrence Handle10.1016/S0895-4356(96)00268-5 Occurrence Handle9048695

    Article  PubMed  Google Scholar 

  • JF Steiner TD Koepsell SD Fihn TS. Inui (1988) ArticleTitleA general method of compliance assessment using centralized pharmacy records Med Care 26 814–23 Occurrence Handle3398608

    PubMed  Google Scholar 

  • H. Enlud (1982) ArticleTitleMeasuring patient compliance in antihypertensive therapy, some methodological aspects J Clin Hosp Pharm 7 43–51 Occurrence Handle7096578

    PubMed  Google Scholar 

  • LL Greenhill JM Halperin H. Abikoff (1999) ArticleTitleStimulant medications J Am Acad Child Adolesc Psychiatr 38 503–12 Occurrence Handle10.1097/00004583-199905000-00011

    Article  Google Scholar 

  • RA Barkley MB McMurray CS Edelbrock K. Robbins (1990) ArticleTitleSide effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation Pediatrics 86 184–92 Occurrence Handle2196520

    PubMed  Google Scholar 

  • D Efron F Jarman M. Barker (1997) ArticleTitleSide effect of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial Pediatrics 100 662–6 Occurrence Handle10.1542/peds.100.4.662 Occurrence Handle9310521

    Article  PubMed  Google Scholar 

  • HM Schachter B Pham J King S Langford D. Moher (2001) ArticleTitleHow efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents?. A meta-analysis Can Med Ass J 165 1475–88

    Google Scholar 

  • D Efron H Hiscock JR Sewell et al. (2003) ArticleTitlePrescribing psychotropic medication for children by Australian pediatricians and child psychiatrists Pediatrics 111 372–5 Occurrence Handle10.1542/peds.111.2.372 Occurrence Handle12563066

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jacqueline G. Hugtenburg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hugtenburg, J.G., Griekspoor, J.E., Boer, I.D. et al. Methylphenidate: Use in Daily Practice. Pharm World Sci 27, 197–201 (2005). https://doi.org/10.1007/s11096-004-2848-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-004-2848-1

Keywords

Navigation